Clinical Trials Browser

Completed × OTHER × midostaurin × Clear all

NCT03900949 2025-10-28

Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01830361 2020-08-06

MIDOKIT

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01477606 2020-06-04

Protocol in Acute Myeloid Leukemia With FLT3-ITD

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01282502 2018-12-12

Midostaurin (PKC412) for Locally Advanced Rectal Cancer

Phase 1 Completed

Gastrointestinal

Rectal Neoplasms

NCT01202877 2018-10-16

PKC412 and 5-Azacytidine

Phase 1/2 Completed

54 enrolled 8 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01161550 2013-07-23

CLAG ATRA AML

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01130662 2013-03-26

Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute